BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 24641801)

  • 41. MiRNA-513a-5p inhibits progesterone receptor expression and constitutes a risk factor for breast cancer: the hOrmone and Diet in the ETiology of breast cancer prospective study.
    Muti P; Donzelli S; Sacconi A; Hossain A; Ganci F; Frixa T; Sieri S; Krogh V; Berrino F; Biagioni F; Strano S; Beyene J; Yarden Y; Blandino G
    Carcinogenesis; 2018 Feb; 39(2):98-108. PubMed ID: 29126102
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A five-microRNA panel in plasma was identified as potential biomarker for early detection of gastric cancer.
    Zhu C; Ren C; Han J; Ding Y; Du J; Dai N; Dai J; Ma H; Hu Z; Shen H; Xu Y; Jin G
    Br J Cancer; 2014 Apr; 110(9):2291-9. PubMed ID: 24595006
    [TBL] [Abstract][Full Text] [Related]  

  • 43. microRNA expression profile in stage III colorectal cancer: circulating miR-18a and miR-29a as promising biomarkers.
    Brunet Vega A; Pericay C; Moya I; Ferrer A; Dotor E; Pisa A; Casalots À; Serra-Aracil X; Oliva JC; Ruiz A; Saigí E
    Oncol Rep; 2013 Jul; 30(1):320-6. PubMed ID: 23673725
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Identification of serum exosomal miR-148a as a novel prognostic biomarker for breast cancer.
    Li D; Wang J; Ma LJ; Yang HB; Jing JF; Jia MM; Zhang XJ; Guo F; Gao JN
    Eur Rev Med Pharmacol Sci; 2020 Jul; 24(13):7303-7309. PubMed ID: 32706068
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Circulating MicroRNAs as easy-to-measure aging biomarkers in older breast cancer patients: correlation with chronological age but not with fitness/frailty status.
    Hatse S; Brouwers B; Dalmasso B; Laenen A; Kenis C; Schöffski P; Wildiers H
    PLoS One; 2014; 9(10):e110644. PubMed ID: 25333486
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Overexpression of circulating miRNA-21 and miRNA-146a in plasma samples of breast cancer patients.
    Kumar S; Keerthana R; Pazhanimuthu A; Perumal P
    Indian J Biochem Biophys; 2013 Jun; 50(3):210-4. PubMed ID: 23898484
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Serum outperforms plasma in small extracellular vesicle microRNA biomarker studies of adenocarcinoma of the esophagus.
    Chiam K; Mayne GC; Wang T; Watson DI; Irvine TS; Bright T; Smith LT; Ball IA; Bowen JM; Keefe DM; Thompson SK; Hussey DJ
    World J Gastroenterol; 2020 May; 26(20):2570-2583. PubMed ID: 32523312
    [TBL] [Abstract][Full Text] [Related]  

  • 48. miR-1254 and miR-574-5p: serum-based microRNA biomarkers for early-stage non-small cell lung cancer.
    Foss KM; Sima C; Ugolini D; Neri M; Allen KE; Weiss GJ
    J Thorac Oncol; 2011 Mar; 6(3):482-8. PubMed ID: 21258252
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Low serum level of miR-485-3p predicts poor survival in patients with glioblastoma.
    Wang ZQ; Zhang MY; Deng ML; Weng NQ; Wang HY; Wu SX
    PLoS One; 2017; 12(9):e0184969. PubMed ID: 28931080
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Direct Comparison of Metastasis-Related miRNAs Expression Levels in Circulating Tumor Cells, Corresponding Plasma, and Primary Tumors of Breast Cancer Patients.
    Markou A; Zavridou M; Sourvinou I; Yousef G; Kounelis S; Malamos N; Georgoulias V; Lianidou E
    Clin Chem; 2016 Jul; 62(7):1002-11. PubMed ID: 27197674
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Pathway Analysis of Selected Circulating miRNAs in Plasma of Breast Cancer Patients: A Preliminary Study.
    Holubekova V; Kolkova Z; Grendar M; Brany D; Dvorska D; Stastny I; Jagelkova M; Zelinova K; Samec M; Liskova A; Laucekova Z; Kudela E; Bobrovska M; Kalman M; Zubor P; Dankova Z
    Int J Mol Sci; 2020 Oct; 21(19):. PubMed ID: 33023154
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Circulating miR-148b and miR-133a as biomarkers for breast cancer detection.
    Shen J; Hu Q; Schrauder M; Yan L; Wang D; Medico L; Guo Y; Yao S; Zhu Q; Liu B; Qin M; Beckmann MW; Fasching PA; Strick R; Johnson CS; Ambrosone CB; Zhao H; Liu S
    Oncotarget; 2014 Jul; 5(14):5284-94. PubMed ID: 25051376
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Overexpression of circulating MiR-30b-5p identifies advanced breast cancer.
    Estevão-Pereira H; Lobo J; Salta S; Amorim M; Lopes P; Cantante M; Reis B; Antunes L; Castro F; Palma de Sousa S; Gonçalves CS; Costa BM; Henrique R; Jerónimo C
    J Transl Med; 2019 Dec; 17(1):435. PubMed ID: 31888645
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Altered profile of serum microRNAs in pancreatic cancer-associated new-onset diabetes mellitus.
    Dai X; Pang W; Zhou Y; Yao W; Xia L; Wang C; Chen X; Zen K; Zhang CY; Yuan Y
    J Diabetes; 2016 May; 8(3):422-33. PubMed ID: 25991015
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Serum miR-128-2 serves as a prognostic marker for patients with hepatocellular carcinoma.
    Zhuang L; Xu L; Wang P; Meng Z
    PLoS One; 2015; 10(2):e0117274. PubMed ID: 25642945
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Persistent upregulation of U6:SNORD44 small RNA ratio in the serum of breast cancer patients.
    Appaiah HN; Goswami CP; Mina LA; Badve S; Sledge GW; Liu Y; Nakshatri H
    Breast Cancer Res; 2011 Sep; 13(5):R86. PubMed ID: 21914171
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Global and targeted circulating microRNA profiling of colorectal adenoma and colorectal cancer.
    Zhang J; Raju GS; Chang DW; Lin SH; Chen Z; Wu X
    Cancer; 2018 Feb; 124(4):785-796. PubMed ID: 29112225
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Plasma microRNAs as potential new biomarkers for early detection of early gastric cancer.
    Zhu XL; Ren LF; Wang HP; Bai ZT; Zhang L; Meng WB; Zhu KX; Ding FH; Miao L; Yan J; Wang YP; Liu YQ; Zhou WC; Li X
    World J Gastroenterol; 2019 Apr; 25(13):1580-1591. PubMed ID: 30983818
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Plasma miR-324-3p and miR-1285 as diagnostic and prognostic biomarkers for early stage lung squamous cell carcinoma.
    Gao X; Wang Y; Zhao H; Wei F; Zhang X; Su Y; Wang C; Li H; Ren X
    Oncotarget; 2016 Sep; 7(37):59664-59675. PubMed ID: 27517633
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A serum microRNA signature predicts trastuzumab benefit in HER2-positive metastatic breast cancer patients.
    Li H; Liu J; Chen J; Wang H; Yang L; Chen F; Fan S; Wang J; Shao B; Yin D; Zeng M; Li M; Li J; Su F; Liu Q; Yao H; Su S; Song E
    Nat Commun; 2018 Apr; 9(1):1614. PubMed ID: 29691399
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.